Jiangsu Yuxing Film Technology Co Ltd
Jiangsu Yuxing Film Technology Co Ltd is a Chinese manufacturer of chemical products, primarily operating in the commodity chemicals segment of the basic materials industry.
Business. Jiangsu Yuxing Film Technology Co Ltd (300305.SZ) is a Chinese chemical manufacturer operating within the commodity chemicals industry. The company is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Jiangsu Yuxing Film Technology Co Ltd (300305.SZ) is a Chinese chemical manufacturer operating within the commodity chemicals industry. The company is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Jiangsu Yuxing Film Technology Co Ltd has a debt-to-equity ratio of 0.45, indicating a relatively conservative capital structure, though its negative net income of -46.68 million CNY and operating loss of -54.27 million CNY suggest financial stress. The company's liquidity position is rated as medium, with a current ratio of 2.42, which is above 1 but not significantly so, and its operating cash flow of 10.98 million CNY is insufficient to cover its capital expenditures of -178.35 million CNY.
Profitability metrics are weak, with a return on equity of -1.84% and a return on assets of -1.14%, both significantly below the industry median for commodity chemicals. The company is currently unprofitable, with a gross loss of -13.84 million CNY, which is a red flag for investors.
The company's revenue is concentrated in a single business segment, as disclosed in its financials, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic and regulatory risks.
Looking ahead, the company is expected to face continued financial pressure, with no clear indication of a turnaround in profitability. The negative operating income and net loss suggest a challenging operating environment, and the capital expenditures are significantly higher than operating cash flow, indicating a need for external financing.
The company's risk profile includes medium liquidity risk, with a negative net cash position after subtracting total debt. While dilution risk is currently rated as low, the company's financial performance and capital structure suggest potential for future dilution if it needs to raise additional capital.
Recent filings and transcripts do not provide specific details on strategic initiatives or operational changes, but the company's financial performance indicates a need for cost management and operational efficiency improvements. The lack of disclosed events or strategic actions suggests a period of operational stagnation.
- The company is currently unprofitable with a negative return on equity and return on assets.
- Liquidity is moderate, but capital expenditures exceed operating cash flow, signaling potential funding needs.
- Revenue is concentrated in a single segment, increasing exposure to sector-specific risks.
- The company's financial performance suggests a need for operational improvements and cost management.
- Dilution risk is currently low, but the financial outlook indicates potential for future capital raising.
Bull / Bear case
Generated · model-assistedFree cash flow improved by 70.3% year-over-year, indicating a significant reduction in cash burn relative to the prior period.
Operating income surged 32.0% year-over-year, demonstrating improved operational efficiency despite ongoing net losses and negative margins.
Net income increased by 28.5% year-over-year, showing a narrowing of losses compared to the previous fiscal period.
Dilution risk is assessed as low, suggesting limited immediate threat to shareholder equity value from share issuance.
Debt-to-equity ratio of 0.45 remains below the cohort median of 0.31, indicating relatively conservative leverage compared to peers.
The company faces high credit risk, raising concerns about its ability to meet financial obligations and service existing debt.
Operating and net margins rank in the bottom quartile of the Commodity Chemicals cohort, indicating severe profitability challenges.
Cash conversion is negative at -0.24, placing it in the bottom quartile and highlighting poor ability to generate cash from operations.
In focus — financials by report
Revenue ¥1.87B, +36,7% YoY; Operating income −43,5% YoY.
- ▍Revenue ¥1.87B, +36,7% YoY
- ▍Operating income −43,5% YoY
- ▍Net income −42,5% YoY
- ▍Free cash flow −2 531,1% YoY
- ▍Net margin 7.4%
Revenue ¥1.37B; Operating income ¥273.2M.
- ▍Revenue ¥1.37B
- ▍Operating income ¥273.2M
- ▍Net margin 17.7%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Jiangsu Yuxing Film Technology Co Ltd Market data — financials · 2026-05-26